PubRank

Ranga R Krishnan

Author PubWeight™ 38.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry 2012 2.94
2 Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006 2.29
3 Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 2007 2.12
4 Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010 1.72
5 Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res 2008 1.66
6 Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004 1.55
7 Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol Drug Saf 2005 1.52
8 Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004 1.44
9 Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008 1.42
10 The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med 2003 1.33
11 Aging, gender, and the elderly adult brain: an examination of analytical strategies. Neurobiol Aging 2006 1.30
12 Decision-making and risk aversion among depressive adults. J Behav Ther Exp Psychiatry 2008 1.16
13 Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 2003 1.12
14 Structural integrity of the uncinate fasciculus in geriatric depression: Relationship with age of onset. Neuropsychiatr Dis Treat 2007 1.11
15 Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial. Am J Med Genet A 2003 1.10
16 Association of depression and survival in patients with chronic heart failure over 12 Years. Psychosomatics 2012 0.99
17 Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway. PLoS One 2013 0.97
18 Amygdala volume in late-life depression: relationship with age of onset. Am J Geriatr Psychiatry 2011 0.96
19 Differences in brain volumes among males and female hormone-therapy users and nonusers. Psychiatry Res 2006 0.95
20 One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes. Am J Geriatr Psychiatry 2011 0.95
21 Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci Rep 2012 0.95
22 Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype. Hum Brain Mapp 2011 0.94
23 Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia. J Med Genet 2009 0.90
24 Incubating the research independence of a medical scientist training program graduate: a case study. Acad Med 2015 0.88
25 Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Arch Pediatr Adolesc Med 2005 0.83
26 Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol 2002 0.82
27 Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression. Psychiatry Res 2009 0.82
28 Hippocampal volumes and depression subtypes. Psychiatry Res 2008 0.82
29 Reductions in neuronal density in elderly depressed are region specific. Int J Geriatr Psychiatry 2009 0.79
30 AGTR1 gene variation: association with depression and frontotemporal morphology. Psychiatry Res 2012 0.78
31 Academic medicine: vision to reality. Ann Acad Med Singapore 2013 0.78
32 Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding. J Cardiovasc Pharmacol Ther 2005 0.77
33 Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia. Neuropsychopharmacology 2011 0.76
34 Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease? Curr Psychiatry Rep 2004 0.75
35 Evidence for the treatment of borderline personality disorder. Psychopharmacol Bull 2003 0.75